Cell-Based Ophthalmic Therapies Global Market Report 2026
상품코드:1951595
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세포 기반 안과 치료 시장 규모는 최근 비약적으로 확대하고 있습니다. 2025년 14억 8,000만 달러에서 2026년에는 17억 9,000만 달러로, CAGR 20.9%로 성장할 것으로 예상됩니다. 지난 수년간의 성장 요인으로는 퇴행성 안질환에 대한 치료 옵션의 한계, 망막 및 각막 질환의 유병률 증가, 고령화 인구 증가, 재생의료에 대한 관심 증가, 안과 연구 인프라 확충 등을 꼽을 수 있습니다.
세포 기반 안과 치료 시장 규모는 향후 몇 년간 급격한 성장이 전망됩니다. 2030년에는 37억 8,000만 달러에 달하고, CAGR은 20.5%가 될 전망입니다. 예측 기간 동안의 성장 요인으로는 줄기세포 및 유전자 편집 기술의 발전, 재생의료 안과에 대한 투자 증가, 세포 기반 치료제의 규제 승인 확대, 장기적인 시력 회복 솔루션에 대한 수요 증가, 전문 안과 치료 센터의 확대 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 시력 회복을 위한 줄기세포 및 유전자 치료의 확대, 망막 및 각막 질환에 대한 재생의료에 대한 관심 증가, 세포 기반 안과 치료 관련 임상시험 증가, 맞춤형 및 정밀 안과 치료의 확대, 기존 안과 치료 대비 장기적인 치료 결과의 개선 등이 있습니다.
안과 질환의 유병률 증가는 향후 몇 년 동안 세포 기반 안과 치료 시장의 성장을 견인할 것으로 예상됩니다. 안과 질환이란 눈에 영향을 미쳐 시력 장애나 눈 건강 전반에 손상을 일으키는 상태 또는 질환을 말합니다. 고령화가 진행되면서 노화 관련 안질환의 위험이 높아지고, 평균수명의 연장이 시력장애율 증가에 기여하고 있어 안과 질환의 발생률은 증가 추세에 있습니다. 세포 기반 안과 치료는 손상된 망막 세포와 안구 세포를 복구 및 대체함으로써 이러한 증상을 해결하고, 시력 회복, 추가 악화 방지, 조직 재생 촉진을 통해 전반적인 안구 기능의 향상을 도모합니다. 예를 들어, 영국 정부 기관인 웨일스 정부에 따르면, 2024년 8월 기준 웨일스 안과 부문의 2023-24년도 입원 환자 수는 35,000명을 넘어 2022-2023년도에 비해 5.8% 증가한 것으로 나타났습니다. 따라서 안과 질환의 유병률 증가는 세포 기반 안과 치료 시장을 성장시키고 있습니다.
세포 기반 안과 치료 시장에서 사업을 전개하는 주요 기업들은 각막 내피 질환 관리의 미충족 수요를 충족시키기 위해 동종 세포 치료와 같은 첨단 치료법 개발에 집중하고 있습니다. 동종세포 치료는 손상된 조직의 복구 및 대체, 질병 치료를 목적으로 같은 종의 유전적으로 다른 개인으로부터 제공받은 줄기세포 및 기타 세포를 이용하는 치료법입니다. 예를 들어, 2024년 9월, 미국에 본사를 둔 임상 단계의 바이오테크 기업 오리온 바이오텍(Aurion Biotech)은 일본에서 '비즈노바(Neltependoxel)'의 상업적 출시를 발표했습니다. 이 치료법은 각막 내피에 영향을 미치는 심각한 질환인 수포성 각막증 치료를 목적으로 합니다. 비스노바는 각막내피질환을 표적으로 하는 최초의 동종세포 치료제로서 일본 규제당국의 승인과 보험적용 승인을 모두 획득한 최초의 동종세포 치료제입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장에서 세계의 총 잠재 시장 규모(TAM)
제9장 시장 세분화
제10장 지역별, 국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자 환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSM
영문 목차
영문목차
Cell-based ophthalmic therapies are treatment approaches for eye disorders that utilize living cells to restore, replace, or safeguard damaged ocular tissues. These therapies address eye conditions that are challenging to manage with conventional treatments by promoting tissue regeneration and improving visual function. They offer innovative, long-term solutions for vision loss and help enhance patients' eyesight and overall quality of life through advances in regenerative medicine.
The main types of cell-based ophthalmic therapies include stem cell therapy, gene therapy, and tissue engineering. Stem cell therapy is a therapeutic approach that employs stem cells to repair, replace, or regenerate damaged or diseased tissues within the body. It is applied in multiple areas such as retinal disorders, corneal disorders, glaucoma, and others, and is utilized by various end users including hospitals, ophthalmic clinics, research institutes, and others.
Tariffs have impacted the cell-based ophthalmic therapies market by increasing the cost of imported cell culture media, bioprocessing equipment, and gene therapy vectors, leading to higher development and manufacturing expenses. Research institutes and hospitals in regions such as North America and Europe, which rely on specialized imports, are most affected. These cost pressures can slow clinical trial progress and therapy commercialization. However, tariffs have also encouraged local manufacturing, regional R&D investments, and innovation in cost-efficient cell processing technologies.
The cell-based ophthalmic therapies market research report is one of a series of new reports from The Business Research Company that provides cell-based ophthalmic therapies market statistics, including cell-based ophthalmic therapies industry global market size, regional shares, competitors with a cell-based ophthalmic therapies market share, detailed cell-based ophthalmic therapies market segments, market trends and opportunities, and any further data you may need to thrive in the cell-based ophthalmic therapies industry. This cell-based ophthalmic therapies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cell-based ophthalmic therapies market size has grown exponentially in recent years. It will grow from $1.48 billion in 2025 to $1.79 billion in 2026 at a compound annual growth rate (CAGR) of 20.9%. The growth in the historic period can be attributed to limited treatment options for degenerative eye diseases, growing prevalence of retinal and corneal disorders, increasing aging population, rising awareness of regenerative medicine, expansion of ophthalmic research infrastructure.
The cell-based ophthalmic therapies market size is expected to see exponential growth in the next few years. It will grow to $3.78 billion in 2030 at a compound annual growth rate (CAGR) of 20.5%. The growth in the forecast period can be attributed to advancements in stem cell and gene editing technologies, increasing investment in regenerative ophthalmology, rising regulatory approvals for cell-based therapies, growing demand for long-term vision restoration solutions, expansion of specialized ophthalmic treatment centers. Major trends in the forecast period include increasing adoption of stem cell and gene therapies for vision restoration, rising focus on regenerative treatments for retinal and corneal disorders, growth in clinical trials for cell-based ophthalmic therapies, expansion of personalized and precision ophthalmic treatments, improved long-term outcomes compared to conventional ophthalmic therapies.
The rising prevalence of ophthalmic disorders is expected to drive the growth of the cell-based ophthalmic therapies market in the coming years. Ophthalmic disorders are conditions or diseases that affect the eyes and lead to vision impairment or damage to overall eye health. The incidence of ophthalmic disorders is increasing as aging populations face a higher risk of age-related eye diseases, with longer life expectancy contributing to greater rates of vision impairment. Cell-based ophthalmic therapies help address these conditions by repairing or replacing damaged retinal and ocular cells, restoring vision, preventing further deterioration, and promoting tissue regeneration to enhance overall eye function. For instance, in August 2024, according to the Welsh Government, a UK-based government agency, ophthalmology departments in Wales reported more than 35,000 admissions in 2023-24, representing a 5.8% increase compared to 2022-2023. Therefore, the increasing prevalence of ophthalmic disorders is driving the growth of the cell-based ophthalmic therapies market.
Major companies operating in the cell-based ophthalmic therapies market are concentrating on the development of advanced treatment approaches, such as allogeneic cell therapy, to address unmet needs in the management of corneal endothelial diseases. Allogeneic cell therapy is a treatment method that utilizes stem cells or other cells donated from a genetically different individual of the same species to repair or replace damaged tissues or treat disease. For example, in September 2024, Aurion Biotech, Inc., a US-based clinical-stage biotechnology company, announced the commercial launch of Vyznova (neltependocel) in Japan. This therapy is intended for the treatment of bullous keratopathy, a severe condition affecting the corneal endothelium. Vyznova is considered the first approved allogeneic cell therapy specifically targeting corneal endothelial disease, having received both regulatory and reimbursement approvals in Japan.
In March 2025, Alcon Inc., a Switzerland-based eye care company, acquired a majority stake in Aurion Biotech, Inc. for an undisclosed amount. Through this acquisition, Alcon aims to advance Aurion Biotech's clinical-stage allogeneic cell therapy candidate, AURN001, into Phase 3 development for the treatment of corneal edema secondary to corneal endothelial disease, while expanding its ophthalmic pharmaceutical portfolio. Aurion Biotech, Inc. is a US-based clinical-stage company focused on developing advanced cell therapies for eye diseases.
Major companies operating in the cell-based ophthalmic therapies market are F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Astellas Pharma Inc., Sumitomo Pharma Co. Ltd., Healios K.K., Lineage Cell Therapeutics, Pandorum Technologies Pvt. Ltd., Neurotech Pharmaceuticals Inc., Coave Therapeutics SAS, jCyte Inc., Eyestem Research Pvt. Ltd., Opsis Therapeutics, Regenerative Patch Technologies LLC, Emmetrope Ophthalmics LLC, GenSight Biologics S.A., MEDIPOST Co. Ltd., Riken, Luxa Biotechnology Inc.
North America was the largest region in the cell-based ophthalmic therapies market in 2025. The regions covered in the cell-based ophthalmic therapies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cell-based ophthalmic therapies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cell-based ophthalmic therapies market consists of revenues earned by entities by providing services such as clinical trial services, ocular cell therapy consultation, post-therapy monitoring and support, research and development services, and regulatory and compliance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell-based ophthalmic therapies market also includes sales of neural progenitor cell injections, bioengineered retinal pigment epithelium scaffolds, autologous mesenchymal stem cell grafts, and ex-vivo expanded conjunctival epithelial cell sheets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cell-Based Ophthalmic Therapies Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cell-based ophthalmic therapies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cell-based ophthalmic therapies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell-based ophthalmic therapies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
4.1.4 Industry 4.0 & Intelligent Manufacturing
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Increasing Adoption Of Stem Cell And Gene Therapies For Vision Restoration
4.2.2 Rising Focus On Regenerative Treatments For Retinal And Corneal Disorders
4.2.3 Growth In Clinical Trials For Cell-Based Ophthalmic Therapies
4.2.4 Expansion Of Personalized And Precision Ophthalmic Treatments
4.2.5 Improved Long-Term Outcomes Compared To Conventional Ophthalmic Therapies
5. Cell-Based Ophthalmic Therapies Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Ophthalmic Clinics
5.3 Research Institutes
5.4 Specialty Eye Centers
5.5 Academic Medical Centers
6. Cell-Based Ophthalmic Therapies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Cell-Based Ophthalmic Therapies Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Cell-Based Ophthalmic Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Cell-Based Ophthalmic Therapies Market Size, Comparisons And Growth Rate Analysis
7.3. Global Cell-Based Ophthalmic Therapies Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Cell-Based Ophthalmic Therapies Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Cell-Based Ophthalmic Therapies Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9.5. Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.6. Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Tissue Engineering, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Cell-Based Ophthalmic Therapies Market
12.1. China Cell-Based Ophthalmic Therapies Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Cell-Based Ophthalmic Therapies Market
13.1. India Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Cell-Based Ophthalmic Therapies Market
14.1. Japan Cell-Based Ophthalmic Therapies Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Cell-Based Ophthalmic Therapies Market
15.1. Australia Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Cell-Based Ophthalmic Therapies Market
16.1. Indonesia Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Cell-Based Ophthalmic Therapies Market
17.1. South Korea Cell-Based Ophthalmic Therapies Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Cell-Based Ophthalmic Therapies Market
19.1. South East Asia Cell-Based Ophthalmic Therapies Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Cell-Based Ophthalmic Therapies Market
20.1. Western Europe Cell-Based Ophthalmic Therapies Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Cell-Based Ophthalmic Therapies Market
21.1. UK Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22.1. Germany Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Cell-Based Ophthalmic Therapies Market
23.1. France Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Cell-Based Ophthalmic Therapies Market
24.1. Italy Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Cell-Based Ophthalmic Therapies Market
25.1. Spain Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Cell-Based Ophthalmic Therapies Market
26.1. Eastern Europe Cell-Based Ophthalmic Therapies Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Cell-Based Ophthalmic Therapies Market
27.1. Russia Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Cell-Based Ophthalmic Therapies Market
28.1. North America Cell-Based Ophthalmic Therapies Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Cell-Based Ophthalmic Therapies Market
29.1. USA Cell-Based Ophthalmic Therapies Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Cell-Based Ophthalmic Therapies Market
31.1. South America Cell-Based Ophthalmic Therapies Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Cell-Based Ophthalmic Therapies Market
32.1. Brazil Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Cell-Based Ophthalmic Therapies Market
33.1. Middle East Cell-Based Ophthalmic Therapies Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Cell-Based Ophthalmic Therapies Market
34.1. Africa Cell-Based Ophthalmic Therapies Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Cell-Based Ophthalmic Therapies Market Regulatory and Investment Landscape
36. Cell-Based Ophthalmic Therapies Market Competitive Landscape And Company Profiles
